热门资讯> 正文

Sensei Biotherapeutics GAAP每股收益为-0.27美元

2025-05-06 23:15

Sensei Biotherapeutics(SNSE) 0

Sensei Biotherapeutics press release (NASDAQ:SNSE): Q1 GAAP EPS of -$0.27.
Cash, cash equivalents and marketable securities were $34.3 million as of March 31, 2025, as compared to $41.3 million as of December 31, 2024.

More on Sensei Biotherapeutics

Seeking Alpha’s Quant Rating on Sensei Biotherapeutics
Historical earnings data for Sensei Biotherapeutics
Financial information for Sensei Biotherapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。